What education recommendations for glucose control should be provided to a patient with diabetes mellitus to help lower hemoglobin A1c?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Education Recommendations for Glucose Control to Lower A1C in Diabetes

Patients with diabetes should receive structured diabetes self-management education (DSME) that includes frequent blood glucose monitoring, proper insulin adjustment techniques, lifestyle modifications (diet and exercise), and recognition of hypoglycemia symptoms, as this approach demonstrably lowers A1C levels.

Core Educational Components

Blood Glucose Monitoring Education

  • Instruct patients on correct glucose meter technique, including proper sample collection and quality control procedures 1
  • For patients on multiple daily insulin injections or insulin pump therapy, educate them to perform blood glucose monitoring at least 4 times daily 1
  • Teach patients to test at critical times: before meals, before bed, and when experiencing symptoms of hypoglycemia or hyperglycemia 1
  • Ensure patients understand that glucose meters should report plasma glucose values (not whole blood) to facilitate comparison with laboratory results 1
  • Provide initial instruction and routine follow-up evaluation of monitoring technique and the patient's ability to use glucose data to adjust therapy 1

Insulin Management Education

  • Educate patients to match prandial insulin doses to carbohydrate intake, preprandial blood glucose levels, and anticipated activity 1
  • Teach patients the onset, peak, and duration of their specific insulin formulations 1
  • When starting SGLT2 inhibitors or GLP-1 receptor agonists, instruct patients to reduce sulfonylurea doses by 50% or basal insulin by 20% if A1C is well-controlled at baseline to prevent hypoglycemia 1
  • Educate patients to monitor glucose more closely at home for the first 4 weeks when starting new glucose-lowering medications 1

Hypoglycemia Recognition and Management

  • Teach patients the signs and symptoms of hypoglycemia (shakiness, sweating, confusion, weakness) and how to manage episodes immediately 1
  • Instruct patients to always carry a source of sugar (glucose tablets, juice, candy) 1
  • Educate family members and close contacts about hypoglycemia and emergency glucagon administration 1
  • Recommend patients wear a medical alert bracelet identifying them as having diabetes 1
  • For patients with hypoglycemia unawareness, consider blood glucose awareness training programs, which can improve A1C, reduce severe hypoglycemia rates, and restore hypoglycemia awareness 1

Lifestyle Modification Education

Dietary Education

  • Provide individualized medical nutrition therapy (MNT) delivered by a registered dietitian familiar with diabetes management 1
  • Educate patients to consume a heart-healthy diet to reduce cardiovascular risk 1
  • Instruct patients to maintain consistent carbohydrate intake and understand carbohydrate counting for insulin dosing 1
  • For patients starting GLP-1 receptor agonists, recommend small portion sizes to mitigate nausea 1

Physical Activity Education

  • Educate patients to engage in at least 150 minutes of moderate-intensity aerobic activity per week 1
  • Teach patients to perform resistance training at least twice weekly 1
  • Instruct patients to reduce sedentary time throughout the day 1
  • Educate patients that exercise regularly improves glycemic control and reduces cardiovascular risk 1

Weight Management Education

  • For overweight or obese patients, educate them to achieve at least 5% body weight loss through lifestyle modifications 1
  • Teach patients that maintaining a healthy weight improves insulin sensitivity and glycemic control 1

Medication-Specific Patient Education

SGLT2 Inhibitor Education

  • Educate patients about genital mycotic infections and the importance of genital hygiene 1
  • Teach patients to recognize symptoms of dehydration (lightheadedness, orthostasis, weakness) and to hold medication if experiencing low oral intake 1
  • Educate patients about diabetic ketoacidosis symptoms (nausea, vomiting, abdominal pain, weakness) and that DKA can occur even with blood glucose readings of 150-250 mg/dL 1
  • Instruct patients regarding foot care, especially those with diabetic neuropathy, and to report foot wounds immediately 1

GLP-1 Receptor Agonist Education

  • Educate patients that nausea is common initially and can be mitigated by starting at the lowest dose and up-titrating slowly 1
  • Advise patients to undergo guideline-recommended eye examinations before starting therapy if not done within the last 12 months 1
  • Inform patients about potential diabetic retinopathy complications with dulaglutide or injectable semaglutide 1

Cardiovascular Risk Reduction Education

  • Educate patients to maintain LDL cholesterol below 100 mg/dL (with therapeutic option of <70 mg/dL for high-risk patients) 1
  • Teach patients to maintain blood pressure below 130/80 mmHg 1
  • Strongly counsel patients who smoke to quit to reduce cardiovascular and microvascular complications 1
  • Educate appropriate patients about daily aspirin therapy to lower coronary heart disease risk by 20-25% 1

Complication Prevention Education

  • Educate patients that tight glycemic control reduces progression of diabetic retinopathy and other microvascular complications 1
  • Instruct patients to receive dilated eye examinations annually starting 3-5 years after type 1 diabetes onset 1
  • Teach patients about screening for microalbuminuria to detect early nephropathy 1
  • Educate patients about the importance of blood pressure control and ACE inhibitor/ARB therapy for nephropathy prevention 1

Educational Delivery Methods

Structured Education Programs

  • Implement immediate rather than delayed education programs, as immediate education achieves greater A1C reduction (-0.72% vs -0.04%) 1
  • Use structured, guideline-based DSME interventions rather than ad hoc education, as structured programs achieve clinically significant A1C reductions (mean -1.8 percentage points) 2
  • Individual education is most effective for A1C reduction in patients with baseline A1C >8%, achieving reductions of -0.3% compared to usual care 3
  • Psychological interventions modestly reduce A1C (mean difference -0.31%) in type 1 diabetes patients 4

Educational Reinforcement

  • Provide ongoing reinforcement and follow-up rather than one-time education sessions 5
  • Reassess patient technique and knowledge regularly to ensure retention and proper application 1
  • Education with printed materials improves both glycemic control and diabetes knowledge when used as an adjunct to verbal education 6

Common Pitfalls to Avoid

  • Do not assume patients understand glucose meter readings—verify they know the difference between plasma and whole blood values 1
  • Do not prescribe frequent monitoring without teaching patients how to use the data to adjust therapy 1
  • Do not start SGLT2 inhibitors or GLP-1 RAs without reducing sulfonylurea or insulin doses in well-controlled patients, as this increases hypoglycemia risk 1
  • Do not provide generic education—tailor content to the patient's specific treatment regimen (diet alone, oral agents, insulin) 6
  • Do not neglect psychological aspects—address diabetes distress, depression, and fear of hypoglycemia, as these significantly impact self-management 1

Related Questions

What is the appropriate management for a 67-year-old adult with mild hyponatremia, hypochloremia, borderline anemia, and impaired fasting glucose?
In a 46-year-old male with BMI 44 kg/m², type 2 diabetes, hypertension, hyperlipidemia, microalbuminuria (urine albumin excretion 680 mg/24 h), and an HbA1c of 13.5 % who is taking glipizide 10 mg twice daily and metformin extended‑release 1000 mg twice daily, what additional medication(s) should be added?
How should I manage a 40-year-old female with type 2 diabetes, recent diabetic ketoacidosis, A1c 13%, persistent hyperglycemia, hypertension at goal, hyperlipidemia, diabetic polyneuropathy, asthma, vitamin D deficiency, and reported non‑compliance?
What should a 61-year-old woman with diabetes do when she develops severe hyperglycemia after starting prednisone 10 mg twice daily for sciatica?
In a 75-year-old male with chronic hyponatremia presumed due to beer potomania, newly elevated serum amylase, and persistently mildly elevated random plasma glucose with a normal hemoglobin A1c, what is the next appropriate step in management?
Can anticoagulation therapy be resumed after a traumatic intracranial hemorrhage?
How should a 21-year-old woman with atypical squamous cells of undetermined significance (ASC-US) on Pap smear and a positive high-risk HPV test be managed?
Which glucagon‑like peptide‑1 (GLP‑1) receptor agonist is the best to initiate in a patient with type 2 diabetes, HbA1c 7.7%, currently taking empagliflozin 25 mg daily and metformin 2000 mg daily?
What is the recommended acute management and long-term relapse prevention therapy for neuromyelitis optica?
What fluconazole dose and treatment duration should be used for an uncomplicated urinary Candida infection in a renal transplant patient receiving tacrolimus?
What is the recommended method to increase (titrate up) prednisolone dosage for managing a myasthenia gravis flare?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.